AM Earnings Preview: Street Neutral, Options Calm, Attention Elevated

Antero Midstream reports Q3 results on October 28 with the Street in a holding pattern and positioning offering few strong convictions ahead of the print.

The analyst consensus is a firm hold, with five holds and just one buy on the register. The most recent target move came from UBS in late September, cutting its price target to $22 from $24 while keeping a Neutral rating. That put UBS and Goldman Sachs both at Neutral, with Wells Fargo at Equal-Weight. The targets cluster in the low $20s, modest upside from the current price of $20.85, suggesting analysts see AM as fairly priced rather than deeply discounted. Forward earnings revisions tell a different story, though. The 12-month forward EPS growth rank scores in the 89th percentile, pointing to meaningful upward estimate momentum even if ratings have not followed. The tension between a cautious consensus and strong EPS revision momentum is the central debate heading into the print.

Options positioning adds no urgency to the setup. The put/call ratio is 0.44, almost exactly in line with its 20-day average of 0.43, and only 0.17 standard deviations above that mean. The ratio has drifted off last week's highs above 0.52 and is nowhere near the 52-week high of 0.54. Separately, the lending market remains entirely uninvested in a bearish outcome. Short interest holds at 2.6% of the free float, broadly unchanged on the week, and availability is vast at over 2,270%, more than 22 shares available to borrow for every one already lent out. Borrowing costs have eased further to 0.39%, down roughly 5% on the week. There is no pressure on this name from the short side.

One data point worth tracking is the spike in retail attention. As noted in the prior ORTEX article on AM, the retail attention z-score has reached 3.84, well above its recent 90-day range, capturing both Wikipedia page views and ORTEX stock-page visits. That reading has not meaningfully changed in the 24 hours since that article was published. Elevated retail attention ahead of a print can reflect investors building familiarity with a name, but the ORTEX dataset carries no directional signal.

The October 28 print is therefore a test of whether AM's forward earnings momentum has substance behind it, and whether management's commentary can shift a Street that has been content to sit at hold while the stock has delivered a roughly 19% gain year-to-date.